Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Experion Holdings Ltd. (V:EXP)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 12556 Stave Lake Rd
Tel: N/A
Website: N/A
Key People
R. Harry McWatters
Chairman of the Board
Jay Garnett
Jarrett Malnarick
Chief Executive Officer, Chief Operating Officer, Senior Vice President, Director
Kamini Hitkari
Chief Financial Officer
Business Overview
Experion Holdings Ltd., formerly Viridium Pacific Group Ltd, is a Canada-based company that is engaged in the medical cannabis sector. Viridium Pacific Group Ltd owns a controlling interest in Experion Biotechnologies Inc (Experion). Experion Biotechnologies Inc is a science-led company that conducts business in the cannabis production industry. Experion Biotechnologies Inc holds a license to produce cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (ACMPR), granted by Health Canada. Experion Biotechnologies Inc's objective is the: production of whole plant, starter material; production of dried marijuana flowers, as well as the distribution of its production, including the wholesale distribution of its starter material to licensed growers and marijuana flower product for wholesale and retail distribution across Canada.
Financial Overview
For the nine months ended 31 August 2019, Experion Holdings Ltd revenues increased from C$0K to C$884K. Net loss increased 69% to C$5.6M. Revenues reflect Production sales increase from C$0K to C$935K. Higher net loss reflects Professional fees increase from C$342K to C$2.5M (expense), Salaries and wages increase from C$180K to C$1.7M (expense), General and administrative increase of 27% to C$1M (expense).
Reporting Currency: Canadian Dollars
Enterprise value: $9.45M as of Aug 31, 2019
Annual revenue (TTM): $1.66M as of Aug 31, 2019
EBITDA (TTM): -$7.80M as of Aug 31, 2019
Net annual income (TTM): -$7.11M as of Aug 31, 2019
Free cash flow (TTM): -$8.36M as of Aug 31, 2019
Net Debt Last Fiscal Year: N/A
Shares outstanding: 100,499,823 as of Dec 13, 2019
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization